Stephen Ma
Director of Finance/CFO at SCILEX HOLDING COMPANY
Net worth: 17 431 $ as of 30/05/2024
Profile
Stephen Ma is currently working as the Secretary, Chief Financial Officer & Senior VP at Scilex Holding Co. He previously worked as the Director-Finance & Operations at Anwita Biosciences, Inc. Mr. Ma has an undergraduate and graduate degree from San Jose State University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
SCILEX HOLDING COMPANY
0.01% | 19/06/2024 | 16,140 ( 0.01% ) | 17 431 $ | 30/05/2024 |
Stephen Ma active positions
Companies | Position | Start |
---|---|---|
SCILEX HOLDING COMPANY | Director of Finance/CFO | 21/09/2023 |
Former positions of Stephen Ma
Companies | Position | End |
---|---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Director of Finance/CFO | 31/12/2021 |
Training of Stephen Ma
San Jose State University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SCILEX HOLDING COMPANY | Health Technology |
Private companies | 1 |
---|---|
Anwita Biosciences, Inc.
Anwita Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Anwita Biosciences, Inc. is a clinical stage biopharmaceutical company located in the US. Anwita's lead product, exenokine-21, has been accepted by China NMPA and the US FDA to initiate clinical studies. The American company specializes in the discovery and development of optimized immunotherapeutics for cancer and autoimmune diseases. Anwita's core technology integrates structure-guided accukine cytokine evolution and accubody discovery of full spectrum nanobodies and antibodies, enabling the development of fully optimized cytokine fusions with superior therapeutic potential, favorable safety profile, and great development ability. The private company's unique product portfolio includes half-live extended exenokines, immune cell- or tumor cell-targeting mableukines, and bi-functional duoleukins. The company is also developing other cytokine-based therapeutics and antibody drug conjugates for the potential treatment of various cancers. | Health Technology |
- Stock Market
- Insiders
- Stephen Ma